Japan’s Ajinomoto has developed a revolutionary enzymatic method to manufacture peptides that could dramatically cut the cost of producing this growing class of therapeutic agents.
Japan’s Ajinomoto has developed a revolutionary enzymatic method to manufacture peptides that could dramatically cut the cost of producing this growing class of therapeutic agents.